About this trial
This study will examine the ways in which telehealth for reproductive healthcare affects timing, costs, and follow-up care; whether telehealth reaches people in areas with greater health inequities; and the attributes of telehealth that patients want. Study surveys will be administered to interested, eligible participants: 2,000 patients seeking abortion care will complete the study, comprising of 2 groups: patients seeking medication abortion care either (1) in-person or (2) via telehealth. This project will address how telehealth services can be optimized for people of color, low-income people, and immigrants to increase digital inclusion and health equity.
Eligibility criteria
Qualifiers
Must be currently or about to be obtaining medication abortion care through in-person or telehealth services
Disqualifiers
Not currently or about to be obtaining medication abortion care through in-person or telehealth services
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
University of California, San Francisco
Lead sponsor
Ibis Reproductive Health
Collaborator
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator